CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives: 

Those participating in this activity will receive information that should allow them to: 

• Understand and maintain the Osteopathic Continuous Certification (OCC) process.
• Gather information necessary to encourage osteopathic board certification.
• Understand AOBIM board initiatives and opportunities.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

J. Rico Blanco, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives: 

Those participating in this activity will receive information that should allow them to: 

• Identify the clinical signs and symptoms supporting the diagnosis of polymyalgia rheumatica and giant cell arteritis.
• Recognize the potential morbidity associated with untreated giant cell arteritis.
• Define the treatment options for polymyalgia rheumatica and giant cell arteritis including strengths and limitations of medication choices.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Linda S. Brecher, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• The metrics commonly used in an acute care setting.
• The importance of these metrics to a hospital provider, and how they can impact them.
• The financial metrics important to the C-suite and hospital finance/revenue cycle teams.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Ariana L. Peters, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• The key challenges and factors influencing the transition from inpatient to outpatient management in chronic pain patients.
• Best practices for developing personalized care plans to facilitate seamless transitions and improve patient outcomes.
• Challenges associated with transitions and solutions to overcome barriers for more effective chronic pain management.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Jean Storm, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Scripting options to counsel patients/families facing serious illness.
• What assistance is available to have difficult conversations.
• Preemptive and management strategies for each conversation.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Annette T. Carron, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• The differences for split shared visits in 2024.
• Physician rules for supervision in 2024.
• The new Hospital and Observation Services codes and guidelines.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Jill M. Young, CPC, CEDC, CIMC, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Define biosimilars in inflammatory diseases.
• Describe issues of concern in the use of biosimilars in clinical practice.
• Summarize team strategies for improving care coordination and communication to advance the use of biosimilars in treating patients with inflammatory diseases.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Brinda Joshi, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• To distinguish hypertensive crises from essential hypertension.
• Management strategies for inpatient and outpatient hypertension management.
• The pertinence of hypertension management to stroke risk reduction and management.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

John Dahdah, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Discuss medical and financial risks associated with obstructive sleep apnea and review choice of the type of sleep study ordered.
• Review choice of the type of sleep study ordered and discuss treatment options for obstructive sleep apnea including stimulator options.
• Review central sleep apnea and medical complications associated and discuss new treatment for central sleep apnea.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Lisa Whims-Squires, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers 1.0 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Updates in management of sleep in hospitalized patients.
• To modify sleep components to improve patient outcomes in hospitalized settings.
• About medications for sleep.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Michelle F. Zetoony-Nudell, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.